OPDC-3
N/A
Report date: 2024/02/05 15:01:12
NME
Base Information
Drug NameOPDC-3
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOncopeptides Ab
China Registration ClassN/A
Develop Information
Active CompaniesUniversity Of HelsinkiOncopeptides Ab
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A